ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Preparing for growth, Exagen Diagnostics, Inc.™ today announced that it moved into larger office space in Austin and hired two directors in newly-created positions in advance of the commercial launch of its first genomic diagnostic test product, which will predict the likelihood of breast cancer metastisis in early-stage patients.
